Jonathan Hirsch

Jonathan Hirsch currently serves as the Chief Strategy and Growth Officer at Paradigm, where efforts focus on creating equitable access to clinical trials by alleviating the burden on physicians. In addition, Jonathan co-founded Synapticure Inc. and holds positions as an investor and advisory board chair. Jonathan is also a partner at Rebel Fund and a seed investor at Protege, contributing to multiple initiatives in the healthcare sector. Educationally, Jonathan holds an A.B. in Biology and Political Science from the University of Chicago and an M.Sci. in Biological Sciences from Stanford University, specializing in Neuroscience, Neurological Diseases, and Therapy Commercialization.